AIM: Lactates accumulate in ischemic brains. G protein-coupled receptor 81 (GPR81) is an endogenous receptor for lactate. We aimed to explore whether lactate is involved in ischemic injury via activating GPR81. METHODS: N2A cells were transfected with GFP-GPR81 plasmids 24 h previously, and then treated with GPR81 antagonist 3-hydroxy-butyrate (3-OBA) alone or cotreated with agonists lactate or 3, 5-dihydroxybenzoic acid (3, 5-DHBA) during 3 h of oxygen-glucose deprivation (OGD). Adult male C57BL/6J mice and primary cultured cortical neurons were treated with 3-OBA at the onset of middle cerebral artery occlusion (MCAO) or OGD, respectively. RESULTS: The GPR81 overexpression increased the cell vulnerability to ischemic injury. And GPR81 antagonism by 3-OBA significantly prevented cell death and brain injury after OGD and MCAO, respectively. Furthermore, inhibition of GPR81 reversed ischemia-induced apoptosis and extracellular signal-regulated kinase (ERK) signaling may be involved in the neuroprotection. CONCLUSIONS: G protein-coupled receptor 81 (GPR81) inhibition attenuated ischemic neuronal death. Lactate may aggravate ischemic brain injury by activating GPR81. GPR81 antagonism might be a novel therapeutic strategy for the treatment of cerebral ischemia.
AIM: Lactates accumulate in ischemic brains. G protein-coupled receptor 81 (GPR81) is an endogenous receptor for lactate. We aimed to explore whether lactate is involved in ischemic injury via activating GPR81. METHODS: N2A cells were transfected with GFP-GPR81 plasmids 24 h previously, and then treated with GPR81 antagonist 3-hydroxy-butyrate (3-OBA) alone or cotreated with agonists lactate or 3, 5-dihydroxybenzoic acid (3, 5-DHBA) during 3 h of oxygen-glucose deprivation (OGD). Adult male C57BL/6J mice and primary cultured cortical neurons were treated with 3-OBA at the onset of middle cerebral artery occlusion (MCAO) or OGD, respectively. RESULTS: The GPR81 overexpression increased the cell vulnerability to ischemic injury. And GPR81 antagonism by 3-OBA significantly prevented cell death and brain injury after OGD and MCAO, respectively. Furthermore, inhibition of GPR81 reversed ischemia-induced apoptosis and extracellular signal-regulated kinase (ERK) signaling may be involved in the neuroprotection. CONCLUSIONS:G protein-coupled receptor 81 (GPR81) inhibition attenuated ischemic neuronal death. Lactate may aggravate ischemic brain injury by activating GPR81. GPR81 antagonism might be a novel therapeutic strategy for the treatment of cerebral ischemia.
Authors: Peter Frykholm; Lars Hillered; Bengt Långström; Lennart Persson; Johann Valtysson; Per Enblad Journal: J Neurosurg Date: 2005-06 Impact factor: 5.115
Authors: Tian-Quan Cai; Ning Ren; Lan Jin; Kang Cheng; Shera Kash; Ruoping Chen; Samuel D Wright; Andrew K P Taggart; M Gerard Waters Journal: Biochem Biophys Res Commun Date: 2008-10-24 Impact factor: 3.575
Authors: Zhi-Gang Xiong; Xiao-Man Zhu; Xiang-Ping Chu; Manabu Minami; Jessica Hey; Wen-Li Wei; John F MacDonald; John A Wemmie; Margaret P Price; Michael J Welsh; Roger P Simon Journal: Cell Date: 2004-09-17 Impact factor: 41.582
Authors: Min Fan; Kun Yang; Xiaohui Wang; Xia Zhang; Jingjing Xu; Fei Tu; P Spencer Gill; Tuanzhu Ha; David L Williams; Chuanfu Li Journal: Shock Date: 2022-09-30 Impact factor: 3.533
Authors: June Zhou; Mark P Burns; Linda Huynh; Sonia Villapol; Daniel D Taub; Juan M Saavedra; Marc R Blackman Journal: Front Endocrinol (Lausanne) Date: 2017-09-11 Impact factor: 5.555